Skip to contentS
Sanara MedTech Inc.
S
SMTISanara MedTech Inc. Q3 2024 · 10-Q
Revenue$21.67M$21.67M+35.2% vs Q3 2023 Net Income-$2.86M-$2.86MN/M vs Q3 2023 EPS Diluted-$0.34-$0.34N/M vs Q3 2023 Gross Profit$19,679,612+37.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sanara MedTech Inc. · CIK 714256 · Engraved from SEC EDGAR
Operating Cash Flowderived$2,050,469+92.7% Free Cash Flowderived$2,041,373+128.4% Margins · derivedGross margin90.8%+1.7 pt vs Q3 2023
Operating margin3.6%+9.3 pt vs Q3 2023
Net margin-13.2%−6.6 pt vs Q3 2023
ended Sep 30, 2024 · filed Nov 12, 2024 · 43 d after period end